Travere Therapeutics Inc Share Price Today: Live Updates & Key Insights
Travere Therapeutics Inc share price today is $26.88, up -3.17%. The stock opened at $27.33 against the previous close of $27.72, with an intraday high of $27.75 and low of $26.16.
Travere Therapeutics Inc Share Price Chart
Travere Therapeutics Inc
Travere Therapeutics Inc Share Price Performance
Travere Therapeutics Inc Institutional Holdings
Travere Therapeutics Inc Market Status
Travere Therapeutics Inc Fundamentals
Market Cap 2475.76 M
PB Ratio 21.5606
PE Ratio 0.0
Enterprise Value 2481.70 M
Total Assets 605.19 M
Volume 2584992
Travere Therapeutics Inc Company Financials
About Travere Therapeutics Inc & investment objective
Company Information Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. Its clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase, a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a collaboration agreement with PharmaKrysto Limited for the pre-clinical activities associated with the cystinuria program. Travere Therapeutics, Inc. was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. The company is headquartered in San Diego, California.
Organisation Biotechnology
Employees 497
Industry Biotechnology
CEO Dr. Eric M. Dube Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Travere Therapeutics Inc FAQs
What is the share price of Travere Therapeutics Inc today?
The current share price of Travere Therapeutics Inc is $26.88.
Can I buy Travere Therapeutics Inc shares in India?
Yes, Indian investors can buy Travere Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Travere Therapeutics Inc shares in India?
You can easily invest in Travere Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Travere Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Travere Therapeutics Inc.
Can I buy fractional shares of Travere Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Travere Therapeutics Inc?
Travere Therapeutics Inc has a market cap of $2475.76 M.
In which sector does Travere Therapeutics Inc belong?
Travere Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Travere Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Travere Therapeutics Inc?
The PE ratio of Travere Therapeutics Inc is N/A and the PB ratio is 21.56.